Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to BDTX Full portfolio

Position in BDTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$534,242
-$923,567 QoQ
Shares Held
288,780
-57.8% QoQ
Ownership
0.503%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 96 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BDTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. BDTX ranks #283 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in BDTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $534,242 288,780
2026-03-31 $1,457,809 684,418
2025-12-31 $790,543 325,327
2025-09-30 $1,701,777 449,018
2025-06-30 $869,596 350,644
2025-03-31 $743,049 479,387
2024-12-31 $1,035,409 483,836
2024-09-30 $1,222,419 281,016
2024-06-30 $294,138 63,120
2024-03-31 $1,689,567 333,248
2023-12-31 $129,217 45,985
2023-03-31 $69,323 36,679
2022-12-31 $66,610 37,006
2022-09-30 $92,912 54,978
2022-06-30 $251,229 102,126
2022-03-31 $501,638 181,097
2021-12-31 $704,391 132,156
2021-09-30 $1,066,856 126,106
2021-06-30 $2,358,301 193,462
2021-03-31 $2,050,648 84,528
2020-12-31 $2,315,804 72,256
2020-09-30 $237,970 7,872
2020-06-30 $717,436 17,017
2020-03-31 $2,246,423 90,037